Follow-Up Extension to the Family Study of Binge Eating Disorder
2012年4月23日 更新者：James I. Hudson, MD、Mclean Hospital
This study involves a 2.5 and 5 year follow-up interview for individuals who participated in the initial family study of binge eating disorder.
The study includes individuals with and without eating disorder as well as their first degree relatives.
As part of the study, participants will be interviewed about their current psychiatric and medical symptoms, their blood pressure will be measured, and laboratory specimens will be obtained.
研究概览
详细说明
Previously we completed a family interview study of 150 individuals with binge eating disorder, 150 matched controls, and approximately 888 of their first degree relatives.
In follow-up to this, we are interviewing these individuals again at 2.5 and 5 years after their initial interview.
During the course of the interview, individuals are asked about their psychiatric and medical history and blood pressure and laboratory specimens are obtained to measure, among other things, fasting lipids and glucose.
研究类型
观察性的
注册 (实际的)
268
联系人和位置
本节提供了进行研究的人员的详细联系信息，以及有关进行该研究的地点的信息。
学习地点
-
-
Massachusetts
-
Belmont、Massachusetts、美国、02478
- McLean Hospital
-
-
参与标准
研究人员寻找符合特定描述的人，称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
18年 及以上 (成人、年长者)
接受健康志愿者
是的
有资格学习的性别
全部
取样方法
非概率样本
研究人群
This study includes individuals with binge eating disorder, individuals without binge eating disorder, and their relatives.
描述
Inclusion Criteria:
- Individuals with or without binge eating disorder and their family members who participated in the initial family study of binge eating disorder and agree to be followed up at 2.5 and 5 years.
Exclusion Criteria:
- Unwilling or unable to participate in the follow-up study.
学习计划
本节提供研究计划的详细信息，包括研究的设计方式和研究的衡量标准。
研究是如何设计的？
设计细节
队列和干预
团体/队列 |
干预/治疗 |
|---|---|
|
Binge eating disorder (BED)
Individuals who meet criteria for binge eating disorder.
|
There is no intervention used in this study.
Cohort members are interviewed and blood pressure, weight, and laboratory specimens are obtained.
|
|
Without BED
Individuals who do not meet criteria for binge eating disorder.
|
There is no intervention used in this study.
Cohort members are interviewed and blood pressure, weight, and laboratory specimens are obtained.
|
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Incidence of Diagnosis of Dyslipidemia
大体时间：Baseline to 5 years
|
The number of participants to acquire a new diagnosis of high cholesterol (dyslipidemia) over the course of the baseline to five-year followup.
|
Baseline to 5 years
|
|
Incidence of Diagnosis of Hypertension
大体时间：Baseline to 5 years
|
The number of participants to acquire a new diagnosis of high blood pressure(hypertension) over the course of the baseline to five-year followup.
|
Baseline to 5 years
|
|
Incidence of Diagnosis of Type 2 Diabetes
大体时间：Baseline to 5 years
|
The number of participants to acquire a new diagnosis of Type 2 Diabetes over the course of the baseline to five-year followup.
|
Baseline to 5 years
|
|
Incidence of Diagnosis of Any Metabolic Syndrome Component
大体时间：Baseline to 5 years
|
The number of participants to acquire a new diagnosis of one component of metabolic syndrome.
Metabolic syndrome can include abdominal obesity, high blood pressure, high cholesterol, etc.
|
Baseline to 5 years
|
|
Incidence of Diagnosis of Two or More Metabolic Syndrome Components
大体时间：Baseline to 5 years
|
The number of participants to acquire a new diagnosis of two or more components of metabolic syndrome.
Metabolic syndrome can include abdominal obesity, high blood pressure, high cholesterol, etc.
|
Baseline to 5 years
|
|
Incidence of Diagnosis of Three or More Metabolic Syndrome Components
大体时间：Baseline to 5 years
|
The number of participants to acquire a new diagnosis of three or more components of metabolic syndrome.
Metabolic syndrome can include abdominal obesity, high blood pressure, high cholesterol, etc.
|
Baseline to 5 years
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
调查人员
- 首席研究员：Harrison G Pope, M.D.、McLean Hospital
出版物和有用的链接
负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查，以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始
2005年6月1日
初级完成 (实际的)
2009年11月1日
研究完成 (实际的)
2009年11月1日
研究注册日期
首次提交
2008年10月20日
首先提交符合 QC 标准的
2008年10月20日
首次发布 (估计)
2008年10月22日
研究记录更新
最后更新发布 (估计)
2012年5月29日
上次提交的符合 QC 标准的更新
2012年4月23日
最后验证
2012年4月1日
更多信息
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.
暴饮暴食症的临床试验
-
Hospital Universitari Vall d'Hebron Research InstituteInstituto de Salud Carlos III完全的
-
Dren BioNovotech招聘中侵袭性 NK 细胞白血病 | 肝脾T细胞淋巴瘤 | 肠病相关的T细胞淋巴瘤 | 皮下脂膜炎样 T 细胞淋巴瘤 | 单形性趋上皮性肠 T 细胞淋巴瘤 | LGLL - 大颗粒淋巴细胞白血病 | 原发性皮肤 T 细胞淋巴瘤 - 类别 | 原发性皮肤 CD8 阳性侵袭性嗜表皮 T 细胞淋巴瘤 | 系统性 EBV1 T 细胞淋巴瘤，如果 CD8 阳性 | Hydroa Vacciniforme-Like Lymphoproliferative Disorder | 结外 NK/T 细胞淋巴瘤，鼻型 | 胃肠道惰性慢性淋巴增生性疾病 (CLPD)（CD8+ 或 NK 衍生） | 上面未列出的其他 CD8+/NK 细胞驱动的淋巴瘤美国, 澳大利亚, 法国, 西班牙
-
Memorial Sloan Kettering Cancer Center招聘中蕈样肉芽肿 | 塞扎里综合症 | 血管免疫母细胞性T细胞淋巴瘤 | 肝脾T细胞淋巴瘤 | 间变性大细胞淋巴瘤，ALK 阳性 | 结外 NK/T 细胞淋巴瘤，鼻型 | T细胞淋巴瘤 | 未特指的外周 T 细胞淋巴瘤 | 原发性皮肤间变性大细胞淋巴瘤 | 皮下脂膜炎样 T 细胞淋巴瘤 | 肠病相关的T细胞淋巴瘤 | 间变性大细胞淋巴瘤，ALK 阴性 | 单形性趋上皮性肠 T 细胞淋巴瘤 | T 细胞幼淋巴细胞白血病 | T 细胞大颗粒淋巴细胞白血病 | 原发性皮肤 CD8 阳性侵袭性嗜表皮 T 细胞淋巴瘤 | Hydroa Vacciniforme-Like Lymphoproliferative Disorder | NK细胞淋巴瘤 | 侵袭性 NK 细胞白血病 | 成人 T 细胞白血病/淋巴瘤 及其他条件美国
No intervention.的临床试验
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); Northwestern University主动，不招人
-
University of Illinois at ChicagoShirley Ryan AbilityLab; Oakland University; Access Living主动，不招人
-
Otsuka Pharmaceutical Factory, Inc.Celerion完全的